Assessment Of Safety Of UK-390,957

Completed · Phase 2/Phase 3

Conditions studied: Ejaculation

In brief

To determine whether UK-390,957 is a safe treatment for premature ejaculation.

Key facts

Study ID

NCT00219609

Run by

Pfizer

People needed

1058

Starts

2005-01-01

Expected to finish

2006-03-01

Last updated by the study team

2012-11-07

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Subjects will have completed one of the phase 2 trials (A3871022/ A3871027/ A3871029) and will have met the diagnostic criteria for premature ejaculation as defined by DSM-IV

You may not qualify if…

• No drug related serious adverse events

Where it is running

• Pfizer Investigational Site — Anaheim, California, United States
• Pfizer Investigational Site — Atherton, California, United States
• Pfizer Investigational Site — Beverly Hills, California, United States
• Pfizer Investigational Site — Laguna Woods, California, United States
• Pfizer Investigational Site — Newport Beach, California, United States
• Pfizer Investigational Site — Redwood City, California, United States
• Pfizer Investigational Site — San Diego, California, United States
• Pfizer Investigational Site — Tarzana, California, United States
• Pfizer Investigational Site — Walnut Creek, California, United States
• Pfizer Investigational Site — Aurora, Colorado, United States
• Pfizer Investigational Site — Waterbury, Connecticut, United States
• Pfizer Investigational Site — Aventura, Florida, United States
• Pfizer Investigational Site — New Port Richey, Florida, United States
• Pfizer Investigational Site — Evansville, Indiana, United States
• Pfizer Investigational Site — Fort Wayne, Indiana, United States
• Pfizer Investigational Site — Indianapolis, Indiana, United States
• Pfizer Investigational Site — Lexington, Kentucky, United States
• Pfizer Investigational Site — Madisonville, Kentucky, United States
• Pfizer Investigational Site — Metairie, Louisiana, United States
• Pfizer Investigational Site — Watertown, Massachusetts, United States
• Pfizer Investigational Site — Saint Clair Shores, Michigan, United States
• Pfizer Investigational Site — Minneapolis, Minnesota, United States
• Pfizer Investigational Site — Southhaven, Mississippi, United States
• Pfizer Investigational Site — Kansas City, Missouri, United States
• Pfizer Investigational Site — Tucson, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.